Compare · BSX vs LMNX
BSX vs LMNX
Side-by-side comparison of Boston Scientific Corporation (BSX) and Luminex Corporation (LMNX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BSX and LMNX operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- BSX carries a market cap of $63.33B.
- BSX has hit the wire 12 times in the past 4 weeks while LMNX has been quiet.
- BSX has more recent analyst coverage (25 ratings vs 0 for LMNX).
- Company
- Boston Scientific Corporation
- Luminex Corporation
- Price
- -
- -
- Market cap
- $63.33B
- -
- 1M return
- -1.52%
- -
- 1Y return
- -57.04%
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 2000
- News (4w)
- 12
- 0
- Recent ratings
- 25
- 0
Boston Scientific Corporation
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
Latest BSX
- Chairman, President & CEO Mahoney Michael F received a gift of 252,241 shares (SEC Form 4)
- SVP, Chief HR Officer O'Sullivan Miriam converted options into 3,871 shares and covered exercise/tax liability with 1,872 shares, increasing direct ownership by 11% to 19,565 units (SEC Form 4)
- Blackstone Life Sciences Announces $455 Million Collaboration to Co-Fund Development of Boston Scientific VITALYST™ Heart Pump for Patients with Cardiogenic Shock
- SEC Form 10-Q filed by Boston Scientific Corporation
- SIMPLAAFY study of the WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device meets primary endpoints
- Boston Scientific downgraded by TD Cowen with a new price target
- Penumbra, Inc. Reports Third Quarter 2026 Financial Results
- Boston Scientific downgraded by Oppenheimer
- Boston Scientific downgraded by Analyst with a new price target
- SEC Form 8-K filed by Boston Scientific Corporation
Latest LMNX
- AdaptHealth Appoints Harriss Currie as Chief Financial Officer
- Defiance ETFs Announces Closure of Select Funds
- SEC Form 15-12G filed by Luminex Corporation
- SEC Form 4: Eck Stephen L. returned $1,408,701 worth of Common Stock to the company (38,073 units at $37.00) , closing all direct ownership in the company (for withholding tax)
- SEC Form 4: ERICKSON THOMAS W returned $6,932,542 worth of Common Stock to the company (187,366 units at $37.00) , closing all direct ownership in the company to cover taxes
- SEC Form 4: KEVER JIM D returned $8,517,363 worth of Common Stock to the company (230,199 units at $37.00) , closing all direct ownership in the company to satisfy withholding obligation
- SEC Form 4: Lewis Dijuana K returned $257,335 worth of Common Stock to the company (6,955 units at $37.00) , closing all direct ownership in the company
- SEC Form 4: MCNAMARA KEVIN M returned $3,713,616 worth of Common Stock to the company (100,368 units at $37.00) , closing all direct ownership in the company to cover withholding tax
- SEC Form 4: OGUNRO EDWARD A returned $2,253,041 worth of Common Stock to the company (60,893 units at $37.00) , closing all direct ownership in the company to cover taxes
- SEC Form 4: SAMET KENNETH A returned $733,229 worth of Common Stock to the company (19,817 units at $37.00) , closing all direct ownership in the company (withholding tax)